Evidence map›Paper›PMID 23274583›Full record

ArticleExperimental eye research2013

NAD(+) maintenance attenuates light induced photoreceptor degeneration.

Shi Bai, Christian T Sheline

Registry-linked trialOpen access · greenAbstract read
In one paragraph

Article in Experimental eye research, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06587945 (A Randomised Double-Masked Placebo-Controlled Trial of Nicotinamide Riboside Oral Supplementation in Macula Off Retinal Detachment), which is not on this map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
0.2field-weighted citation impact, top 51% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06587945 phase4recruitingnot on this mapstarted 2025, after this paper: background citation

A Randomised Double-Masked Placebo-Controlled Trial of Nicotinamide Riboside Oral Supplementation in Macula Off Retinal Detachment

TypeinterventionalSponsorCenter for Eye Research AustraliaRan2025 to 2028Enrolled144ConditionsRetinal DetachmentArmsNicotinamide Riboside, Placebo, Vitrectomy and Gas tamponade
3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 21 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Implications of NADOxidative medicine and cellular longevity · 2020
    Review
  8. Article
  9. BioMed research international · 2019
    Article
  10. Review
  11. Article
  12. Reductive carboxylation is a major metabolic pathway in the retinal pigment epithelium.Proceedings of the National Academy of Sciences of the United States of America · 2016
    Article
  13. Article
  14. Article
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Shi BaiDept. of Ophthalmology and the Neuroscience Center of Excellence, LSU Health Sciences Center, 2020 Gravier Street, Suite D, New Orleans, LA 70112, USA. sbai@lsuhsc.edu
Christian T Sheline
Louisiana State University Health Sciences Center New Orleans · US

Funding

Multiphoton ConfocalP30GM103340 · NIGMS · LSU HEALTH SCIENCES CENTER · PI BAZAN, NICOLAS G. · 2012 to 2016
$5.1M
Type-1 Diabetes: Zn2+ Potentiated Beta-Cell Death By Sirtuin-Mediated NAD+ LossR01DK073446 · NIDDK · WASHINGTON UNIVERSITY · PI SHELINE, CHRISTIAN THOMAS · 2006 to 2010
$1.5M
NIDDK NIH HHS DK 073446NIDDK NIH HHS R01 DK073446NIGMS NIH HHS P30 GM103340
6 · The paper itself

Abstract

Light-induced retinal damage (LD) occurs after surgery or sun exposure. We previously showed that zinc (Zn(2+)) accumulated in photoreceptors and RPE cells after LD but prior to cell death, and pyruvate or nicotinamide attenuated the resultant death perhaps by restoring nicotinamide adenine dinucleotide (NAD(+)) levels. We first examined the levels of NAD(+) and the efficacy of pyruvate or nicotinamide in oxidative toxicities using primary retinal cultures. We next manipulated NAD(+) levels in vivo and tested the affect on LD to photoreceptors and RPE. NAD(+) levels cycle with a 24-h rhythm in mammals, which is affected by the feeding schedule. Therefore, we tested the affect of increasing NAD(+) levels on LD by giving nicotinamide, inverting the feeding schedule, or using transgenic mice which overexpress cytoplasmic nicotinamide mononucleotide adenyl-transferase-1 (cytNMNAT1), an NAD(+) synthetic enzyme. Zn(2+) accumulation was also assessed in culture and in retinal sections. Retinas of light damaged animals were examined by OCT and plastic sectioning, and retinal NAD(+) levels were measured. Day fed, or nicotinamide treated rats showed less NAD(+) loss, and LD compared to night fed rats or untreated rats without changing the Zn(2+) staining pattern. CytNMNAT1 showed less Zn(2+) staining, NAD(+) loss, and cell death after LD. In conclusion, intense light, Zn(2+) and oxidative toxicities caused an increase in Zn(2+), NAD(+) loss, and cell death which were attenuated by NAD(+) restoration. Therefore, NAD(+) levels play a protective role in LD-induced death of photoreceptors and RPE cells.

Indexed as

AnimalsAntioxidantsCell DeathCells, CulturedCircadian RhythmCytoprotectionDisease Models, AnimalFeeding BehaviorHydrogen PeroxideLightMiceMice, Inbred C57BLMice, TransgenicNADNiacinamideNicotinamide-Nucleotide AdenylyltransferaseAntioxidantsHydrogen PeroxideNADNiacinamideNicotinamide-Nucleotide AdenylyltransferaseOxidantsPyruvic AcidZinc

Identifiers

PMID23274583
PMCPMC3578030
OpenAlexW1998785748

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.